ad

Sudeep Pharma Ltd. (SUDEEPPHRM): Sudeep Pharma Share Price Hits Fresh 52-Week High at Rs 1,156.25

19 Aug 20263:26 pm

Sudeep Pharma Ltd. (SUDEEPPHRM): Sudeep Pharma Share Price Hits Fresh 52-Week High at Rs 1,156.25

Sudeep Pharma Share Price rose 3.85% to Rs 1,143.65 after hitting a fresh 52-week high of Rs 1,156.25. The company’s market capitalisation stood at Rs 12,412.49 crore.

Sudeep Pharma Share Price was at Rs 1,143.65 on 19 August 2026, up Rs 42.45 or 3.85% for the day, after touching a fresh 52-week high of Rs 1,156.25. With a market capitalisation of Rs 12,412.49 crore, the stock has entered the list of closely watched 52 Week High Stocks in today’s Indian Stock Market action. The supplied data confirms the price event clearly, even though it does not establish a company-specific catalyst behind the move.

For investors tracking Sudeep Pharma Share Price Today, the session stood out because the stock opened at Rs 1,101.20, the same as its previous close, and then moved higher through the day. That pattern matters in Stock Market Today coverage because it points to intraday follow-through rather than a gap-led spike alone. Univest notes that the move also pushed the stock to a new one-year high, making it relevant for traders following breakout stocks and longer-term investors monitoring yearly highs.

In practical terms, the verified data puts attention on three factors: the stock’s fresh 52-week peak, its Rs 2.52 crore turnover with 22,078 shares traded, and its valuation profile against the broader Healthcare sector benchmark. That makes this a useful moment for price action review, Sudeep Pharma Fundamental Analysis, peer comparison and sector context rather than speculation about unverified triggers.

Sudeep Pharma Share Price Today: Price Action Analysis

Metric Value
Current Price Rs 1,143.65
Previous Close Rs 1,101.2
Today's Change +Rs 42.45 (+3.85%)
Day Open Rs 1,101.2
Fresh 52-Week High Rs 1,156.25
Day Low Rs 1,101.2
Current Volume 22,078
Turnover Rs 2.52 crore
Market Capitalisation Rs 12,412.49 crore

Sudeep Pharma Ltd. (SUDEEPPHRM) traded at Rs 1,143.65. versus the previous close of Rs 1,101.2, a rise of 3.85%. The stock opened at Rs 1,101.2, reached Rs 1,156.25, touched Rs 1,101.2. Reported volume was 22,078.

Sudeep Pharma Share Price Today reflects a strong session in verified price terms: the stock opened at Rs 1,101.20, matched the previous close of Rs 1,101.20, climbed as high as Rs 1,156.25 and was trading at Rs 1,143.65, up 3.85%. The move places the stock at a fresh 52-week high and keeps it firmly in market conversation.

What exactly happened today? Sudeep Pharma Share Price began the day at Rs 1,101.20 and never traded below that level, with the day’s low also at Rs 1,101.20. From there, the stock advanced to Rs 1,156.25 before easing slightly to Rs 1,143.65. That means the stock remained well above the previous close through the session and closed the gap between opening stability and upward intraday price action with a clear move into a new 52-week peak.

The day change of Rs 42.45 shows a meaningful single-session gain, while turnover of Rs 2.52 crore and current volume of 22,078 indicate active participation. In market news terms, that combination of a new one-year high and live trading interest is one reason Sudeep Pharma Stock News is drawing attention. The price action alone confirms the event; it does not, on the supplied data, confirm a specific corporate trigger. From here, the next question is whether the company’s valuation and profitability metrics support continued investor tracking.

Sudeep Pharma Ltd. (SUDEEPPHRM) Fundamental Analysis

Metric Value
Market Capitalisation Rs 12,412.49 crore
P/E Ratio 51.17x
P/B Ratio 2.03x
ROE -0.78%
ROCE 8.31%

Sudeep Pharma Ltd. was valued at a P/E ratio of 51.17x, a P/B ratio of 2.03x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of -0.78% and ROCE of 8.31%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Sector and Industry Context

Metric Value
Sector Healthcare
Benchmark Scope same sector
Company P/E Ratio 51.17x
Benchmark Median P/E 20.79x
Benchmark Average P/E 47.16x
Benchmark P/E Range 0x to 1,635.98x
Company P/B Ratio 2.03x
Benchmark Median P/B 1.9x
Company ROE -0.78%
Benchmark Median ROE 11.09%
Company ROCE 8.31%
Benchmark Median ROCE 13.29%
Company Market Capitalisation Rs 12,412.49 crore
Benchmark Median Market Cap Rs 134.22 crore

Sudeep Pharma Ltd. (SUDEEPPHRM) is classified under sector: Healthcare.

Sudeep Pharma Ltd. (SUDEEPPHRM) has a P/E ratio of 51.17x, which is above the benchmark median of 20.79x, a difference of +146.13%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Sudeep Pharma Ltd. (SUDEEPPHRM) has a ROE of -0.78%, which is below the benchmark median of 11.09%, a difference of -107.03%. Sudeep Pharma Ltd. (SUDEEPPHRM) has a ROCE of 8.31%, which is below the benchmark median of 13.29%, a difference of -37.47%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company Symbol Market Cap (Cr) P/E P/B ROE (%) ROCE (%)
Ind-Swift Laboratories Ltd. INDSWFTLAB 2,724.51 51.17 2.03 -0.78 8.31
Beta Drugs Ltd. BETA 2,697.08 62.93 9.96 18.65 22.17
Dr Agarwals Eye Hospital Ltd. DRAGARWQ 2,583.65 33.9 6.99 36.29 42.4
Sai Parenteral's Ltd. SAIPARENT 2,431.62 167.79 3.07 13.9 12.97
Fredun Pharmaceuticals Ltd. FREDUN 2,403.56 54.45 8.13 11.42 13.15

Sudeep Pharma Ltd. (SUDEEPPHRM) has a P/E ratio of 51.17x compared with the displayed peer median of 54.45x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -0.78% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at 8.31% versus the displayed peer median of 13.15%, providing a capital-efficiency comparison. Sudeep Pharma Ltd. (SUDEEPPHRM) has a market capitalisation of Rs 12,412.49 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching Sudeep Pharma

This stock is attracting attention because the verified data shows a clear event-led move, large company size and valuation metrics that invite comparison with the broader Healthcare pack. The focus remains on observable numbers rather than unverified explanations.

  • Fresh 52-week high: Sudeep Pharma Share Price touched Rs 1,156.25 and was up 3.85% at Rs 1,143.65.
  • Intraday strength: The stock opened at Rs 1,101.20, matched the day’s low at Rs 1,101.20 and then moved higher.
  • Trading activity: Current volume stood at 22,078 shares with turnover of Rs 2.52 crore.
  • Valuation context: P/E at 51.17 is above the Healthcare median of 20.79 and average of 47.16.
  • Profitability context: ROE of -0.78% and ROCE of 8.31% are below the sector median and average.
  • Scale factor: Market capitalisation of Rs 12,412.49 crore is above the benchmark maximum market cap of Rs 2,752.33 crore in the supplied sector set.

About Sudeep Pharma

Sudeep Pharma Ltd. (SUDEEPPHRM) is presented in the supplied market dataset as a Healthcare company. The broader comparison framework places it alongside Healthcare and Pharmaceuticals & Drugs names, which is why its valuation and profitability are being compared against the same sector benchmark and a selected peer group.

Based on the verified inputs available for this article, Sudeep Pharma is being tracked primarily through its market metrics rather than a detailed business profile. In today’s context, the company is notable for its market capitalisation of Rs 12,412.49 crore and for the fact that Sudeep Pharma Share Price has moved to a fresh one-year high. That combination keeps the stock relevant in NSE News and BSE News screens focused on Top Gainers Today, Market Movers and 52 Week High Stocks.

For investors and market readers, the practical significance of the company right now lies in how its stock performance is interacting with sector valuations, peer positioning and intraday price action. As more verified company data appears on Univest over time, users can place these market signals alongside deeper company financials and broader business context.

Track Sudeep Pharma Share Price on Univest

Use Sudeep Pharma Ltd. (SUDEEPPHRM) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

On Univest, users can track Sudeep Pharma Share Price, Sudeep Pharma Share Price Today and Sudeep Pharma Share Price Live alongside 52-week levels, market insights and stock updates. The platform also helps users follow valuation ratios such as P/E and P/B, company profitability metrics including ROE and ROCE, shareholding pattern when available, and broader sector comparisons.

For readers monitoring Sudeep Pharma Latest News, Univest provides a structured way to view price action, market cap, peer positioning and company-level financial indicators in one place. That is especially useful when a stock enters trending screens because of a fresh 52-week high rather than a disclosed corporate announcement. In that setting, Sudeep Pharma Share Price can be reviewed with context instead of in isolation.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions

What is the latest Sudeep Pharma Share Price Today?

Ans. Sudeep Pharma Share Price Today was Rs 1,143.65 on 19 August 2026, up Rs 42.45 or 3.85% from the previous close of Rs 1,101.20. The stock also touched a fresh 52-week high of Rs 1,156.25 during the session.

Why is Sudeep Pharma Share Price in the news today?

Ans. Sudeep Pharma Share Price is in focus because the stock reached a fresh 52-week high of Rs 1,156.25. It was trading at Rs 1,143.65 with a 3.85% gain, supported by turnover of Rs 2.52 crore and volume of 22,078 shares.

What was the fresh 52-week high for Sudeep Pharma?

Ans. The fresh 52-week high for Sudeep Pharma was Rs 1,156.25. The stock opened at Rs 1,101.20, which was also the day’s low, and then climbed to the new one-year high before trading slightly below that level.

How much did Sudeep Pharma Share Price rise today?

Ans. Sudeep Pharma Share Price rose by Rs 42.45 today, which translates into a gain of 3.85% over the previous close of Rs 1,101.20. The move placed the stock among notable market movers tracking fresh yearly highs.

What does today's price action show for Sudeep Pharma?

Ans. Today’s price action shows steady intraday strength. Sudeep Pharma opened at Rs 1,101.20, did not fall below that level, hit Rs 1,156.25 and traded at Rs 1,143.65 later, indicating sustained buying interest through the session.

What is the market capitalisation of Sudeep Pharma?

Ans. Sudeep Pharma had a market capitalisation of Rs 12,412.49 crore in the supplied data. That is far above the Healthcare sector benchmark median of Rs 134.22 crore and average of Rs 465.93 crore in the same-sector sample.

What valuation ratios are available for Sudeep Pharma?

Ans. The supplied valuation metrics show a P/E ratio of 51.17 and a P/B ratio of 2.03 for Sudeep Pharma. Compared with the Healthcare benchmark, its P/E is above both the median 20.79 and average 47.16.

How do Sudeep Pharma's profitability ratios compare with the sector?

Ans. Sudeep Pharma’s ROE is -0.78% and ROCE is 8.31%. Both are below the Healthcare benchmark figures, where median ROE is 11.09%, average ROE is 15.58%, median ROCE is 13.29% and average ROCE is 17.78%.

How does Sudeep Pharma compare with selected peers?

Ans. In the supplied peer set, Sudeep Pharma stands out for scale with market capitalisation of Rs 12,412.49 crore, while peers such as Beta Drugs, Dr Agarwals Eye Hospital and Fredun Pharmaceuticals show stronger ROE and ROCE figures.

What should investors monitor next in Sudeep Pharma Stock News?

Ans. Investors can monitor whether Sudeep Pharma holds near its fresh 52-week peak, how turnover and volume evolve after today’s 3.85% gain, and how its valuation and profitability metrics compare with peers and the broader Healthcare benchmark.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5
ad

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited

Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003

Write to us : support@univest.in, compliance@univest.in

Verify on SEBI registry →

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down